DOI:
10.1055/s-00000021
Gesundheitsökonomie & Qualitätsmanagement
LinksClose Window
References
Nilsson J, Åkerborg Ö, Bego-le BagousseG et al.
Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs, for the treatment of atrial fibrillation, based on the ATHENA clinical trial.
Eur j of Health Econ 2012;
14: 481-493
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.